The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 06, 2024
Filed:
Oct. 28, 2022
Applicant:
Merck Patent Gmbh, Darmstadt, DE;
Inventors:
Ilhan Celik, Zwingenberg, DE;
Eike Staub, Darmstadt, DE;
Miriam Urban, Leidersbach, DE;
Sabine Raab-Westphal, Rosbach, DE;
Eileen Samy, Arlington, MA (US);
Andrew Bender, Reading, MA (US);
Georgianna Varrone, Tewksbury, MA (US);
Yin Wu, Andover, MA (US);
Daigen Xu, Westford, MA (US);
Assignee:
Merck Patent GmbH, Darmstadt, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61P 11/00 (2006.01); A61P 17/02 (2006.01); C07K 16/28 (2006.01); C12Q 3/00 (2006.01); G01N 33/543 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2848 (2013.01); A61K 39/395 (2013.01); A61P 11/00 (2018.01); A61P 17/02 (2018.01); C07K 16/2839 (2013.01); C12Q 3/00 (2013.01); G01N 33/54366 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01);
Abstract
A method can treat a patient suffering from at least one of fibrosis and a fibrotic disorder. The method includes administering a therapeutically effective amount of an anti-αv integrin antibody DI17E6, or a biologically active variant or modification thereof, to the patient.